Your browser is no longer supported. Please, upgrade your browser.
Settings
ABIO [NASD]
ARCA biopharma, Inc.
Index- P/E- EPS (ttm)-1.93 Insider Own0.40% Shs Outstand14.41M Perf Week-1.90%
Market Cap52.20M Forward P/E- EPS next Y- Insider Trans107.76% Shs Float14.35M Perf Month8.08%
Income-12.50M PEG- EPS next Q- Inst Own6.10% Short Float2.25% Perf Quarter-13.64%
Sales- P/S- EPS this Y50.20% Inst Trans6.39% Short Ratio1.02 Perf Half Y-12.38%
Book/sh5.33 P/B0.68 EPS next Y- ROA-27.30% Target Price- Perf Year-48.13%
Cash/sh4.63 P/C0.78 EPS next 5Y- ROE-28.90% 52W Range2.92 - 8.61 Perf YTD-9.98%
Dividend- P/FCF- EPS past 5Y42.50% ROI- 52W High-58.07% Beta2.73
Dividend %- Quick Ratio23.90 Sales past 5Y- Gross Margin- 52W Low23.63% ATR0.16
Employees11 Current Ratio23.90 Sales Q/Q- Oper. Margin- RSI (14)51.70 Volatility3.87% 3.99%
OptionableYes Debt/Eq0.00 EPS Q/Q59.90% Profit Margin- Rel Volume0.67 Prev Close3.66
ShortableYes LT Debt/Eq0.00 EarningsMay 11 AMC Payout- Avg Volume316.46K Price3.61
Recom- SMA201.19% SMA504.61% SMA200-11.72% Volume210,560 Change-1.37%
Feb-27-18Initiated Ascendiant Capital Markets Buy $2
Oct-09-13Initiated Dawson James Buy $3.75
May-11-21 04:15PM  
May-05-21 04:05PM  
May-03-21 04:30PM  
Mar-18-21 04:30PM  
Feb-13-21 01:09AM  
Dec-15-20 08:30AM  
Dec-09-20 05:40PM  
Nov-23-20 12:28PM  
08:30AM  
Nov-02-20 08:30AM  
Oct-07-20 08:30AM  
Oct-05-20 04:30PM  
Sep-21-20 08:00AM  
Aug-17-20 08:49AM  
Aug-12-20 08:00AM  
Aug-05-20 04:15PM  
Jul-07-20 08:30AM  
Jun-03-20 09:56AM  
09:56AM  
Jun-01-20 08:20AM  
May-29-20 12:24PM  
09:59AM  
May-28-20 04:19PM  
12:14PM  
10:27AM  
08:00AM  
May-07-20 08:30AM  
May-06-20 04:30PM  
Feb-18-20 04:30PM  
Feb-01-20 08:31AM  
Nov-06-19 04:10PM  
Nov-03-19 08:47AM  
Sep-12-19 08:30AM  
Sep-11-19 08:30AM  
Sep-04-19 01:37PM  
Aug-21-19 09:49AM  
Aug-01-19 04:30PM  
Jun-04-19 07:09AM  
May-13-19 09:00AM  
May-08-19 04:30PM  
May-01-19 08:30AM  
Apr-23-19 08:30AM  
Mar-18-19 08:30AM  
Mar-06-19 08:00AM  
Feb-27-19 04:15PM  
Feb-20-19 07:30AM  
Jan-16-19 08:30AM  
Dec-26-18 11:47AM  
Dec-20-18 04:01PM  
Nov-14-18 04:30PM  
Nov-12-18 08:30AM  
Nov-05-18 08:30AM  
Oct-10-18 04:16PM  
Oct-02-18 08:00AM  
Sep-18-18 08:30AM  
Aug-09-18 04:15PM  
Aug-03-18 09:45AM  
Jul-31-18 12:15PM  
08:30AM  
08:10AM  
Jun-19-18 07:05AM  
May-29-18 08:30AM  
May-11-18 08:20AM  
May-10-18 08:30AM  
07:15AM  
May-08-18 04:15PM  
Apr-23-18 08:30AM  
Apr-03-18 07:20AM  
Mar-22-18 04:30PM  
Feb-27-18 03:00PM  
Feb-26-18 02:18PM  
08:00AM  
Jan-23-18 05:13PM  
Jan-08-18 08:30AM  
Jan-02-18 05:09PM  
Dec-08-17 06:13PM  
Nov-30-17 02:25PM  
Nov-20-17 08:05AM  
Nov-17-17 08:10AM  
Nov-16-17 08:30AM  
Nov-09-17 04:05PM  
Oct-23-17 08:16PM  
Sep-21-17 08:30AM  
Aug-16-17 08:30AM  
Aug-09-17 04:30PM  
Aug-03-17 04:15PM  
Jun-20-17 08:30AM  
May-15-17 08:30AM  
Apr-26-17 08:30AM  
Apr-18-17 08:30AM  
Mar-25-17 01:04PM  
Mar-21-17 04:46PM  
04:30PM  
04:10PM  
Mar-06-17 04:32PM  
08:30AM  
Mar-01-17 04:47PM  
Feb-21-17 08:46AM  
08:30AM  
Jan-18-17 04:32PM  
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase 2 clinical trial for the treatment of diseases caused by ribonucleic acid viruses initially focusing on COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase 2 trial for the treatment of atrial fibrillation in patients with chronic heart failure (HF). The company also engages in the development of AB171, a thiol-containing derivative isosorbide mononitrate for the treatment of HF and peripheral arterial disease. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CONWAY ROBERT EChairman of the BoardMay 12Buy3.1910,00031,94750,000May 13 05:00 PM
CONWAY ROBERT EChairman of the BoardMay 05Buy3.2310,00032,34540,000May 06 04:30 PM
CONWAY ROBERT EChairman of the BoardDec 18Buy4.1610,00041,63030,000Dec 21 04:15 PM
CONWAY ROBERT EChairman of the BoardSep 25Buy4.285,00021,39920,000Sep 25 04:20 PM
CONWAY ROBERT EChairman of the BoardSep 22Buy4.663,05614,24115,000Sep 24 04:20 PM
CONWAY ROBERT EChairman of the BoardSep 21Buy4.7710,00047,66011,944Sep 21 05:00 PM